Introduction
This study is be paired with the compassionate use treatment study with baricitinib (oral JAK inhibitor) to help assess outcomes.
To get started:
- Navigate through the menu to learn more about the study.
- Log in to the application and fill out questionnaires.
Please contact us if you have any questions or concerns.